showed a trendp = 0.09
For vasodilators/nitrates, used by 11 participants (6 cases, 5 controls), hsa-miR-126-3p showed a trend toward higher expression in users (median 119.5) compared to non-users (median 29.0, p = 0.09).
For vasodilators/nitrates, used by 11 participants (6 cases, 5 controls), hsa-miR-126-3p showed a trend toward higher expression in users (median 119.5) compared to non-users (median 29.0, p = 0.09).